Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial

BACKGROUND Wolbachia endosymbionts of filarial nematodes are vital for larval development and adult-worm fertility and viability. This essential dependency on the bacterium for survival of the parasites has provided a new approach to treat filariasis with antibiotics. We used this strategy to investigate the effects of doxycycline treatment on the major cause of lymphatic filariasis, Wuchereria bancrofti. METHODS We undertook a double-blind, randomised, placebo-controlled field trial of doxycycline (200 mg per day) for 8 weeks in 72 individuals infected with W bancrofti from Kimang'a village, Pangani, Tanzania. Participants were randomly assigned by block randomisation to receive capsules of doxycycline (n=34) or placebo (n=38). We assessed treatment efficacy by monitoring microfilaraemia, antigenaemia, and ultrasound detection of adult worms. Follow-up assessments were done at 5, 8, 11, and 14 months after the start of treatment. Analysis was per protocol. FINDINGS One person from the doxycycline group died from HIV infection. Five (doxycycline) and 11 (placebo) individuals were absent at the time of ultrasound analysis. Doxycycline treatment almost completely eliminated microfilaraemia at 8-14 months' follow-up (for all timepoints p<0.001). Ultrasonography detected adult worms in only six (22%) of 27 individuals treated with doxycycline compared with 24 (88%) of 27 with placebo at 14 months after the start of treatment (p<0.0001). At the same timepoint, filarial antigenaemia in the doxycycline group fell to about half of that before treatment (p=0.015). Adverse events were few and mild. INTERPRETATION An 8-week course of doxycycline is a safe and well-tolerated treatment for lymphatic filariasis with significant activity against adult worms and microfilaraemia.

[1]  M. Donnelly,et al.  Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[2]  A. Hoerauf,et al.  Mass drug treatment for lymphatic filariasis and onchocerciasis. , 2003, Trends in parasitology.

[3]  B. Duke,et al.  Strategies and tools for the control/elimination of lymphatic filariasis. , 1997, Bulletin of the World Health Organization.

[4]  D. Freedman,et al.  Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis , 2001, Tropical medicine & international health : TM & IH.

[5]  M. Taylor,et al.  Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. , 2000, Annals of tropical medicine and parasitology.

[6]  A. Hoerauf,et al.  Wolbachia bacteria of filarial nematodes. , 1999, Parasitology today.

[7]  Marilyn Roberts,et al.  Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.

[8]  T. Klei,et al.  Brugia pahangi and Wolbachia: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline treatment. , 2003, Experimental parasitology.

[9]  G. Weil,et al.  Bancroftian filariasis in Egypt: visualization of adult worms and subclinical lymphatic pathology by scrotal ultrasound. , 1998, The American journal of tropical medicine and hygiene.

[10]  A. Hoerauf,et al.  Doxycycline as a novel strategy against bancroftian filariasis—depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production , 2003, Medical Microbiology and Immunology.

[11]  A. Hoerauf,et al.  Antibiotics for the treatment of onchocerciasis and other filarial infections. , 2002, Current opinion in investigational drugs.

[12]  A. Hoerauf,et al.  A new approach to the treatment of filariasis , 2001, Current opinion in infectious diseases.

[13]  A. Hoerauf,et al.  The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River Blindness , 2002, Science.

[14]  Mark J. Taylor,et al.  Inflammatory Responses Induced by the Filarial Nematode Brugia malayi Are Mediated by Lipopolysaccharide-like Activity from Endosymbiotic Wolbachia Bacteria , 2000, The Journal of experimental medicine.

[15]  T. Nutman,et al.  Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. , 2002, The Journal of infectious diseases.

[16]  J. Archer,et al.  16S rDNA phylogeny and ultrastructural characterization of Wolbachia intracellular bacteria of the filarial nematodes Brugia malayi, B. pahangi, and Wuchereria bancrofti. , 1999, Experimental parasitology.

[17]  M. Alpers,et al.  Mass treatment to eliminate filariasis in Papua New Guinea. , 2002, The New England journal of medicine.

[18]  A. Cedenho,et al.  The histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease , 2002, Annals of tropical medicine and parasitology.

[19]  D. Addiss,et al.  Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  A. Hoerauf,et al.  Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis , 2003, Filaria journal.

[21]  A. Hoerauf,et al.  Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. , 2003, Microbes and infection.

[22]  A. Hoerauf,et al.  Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis , 2000, The Lancet.

[23]  R. Rao,et al.  IN VITRO EFFECTS OF ANTIBIOTICS ON BRUGIA MALAYI WORM SURVIVAL AND REPRODUCTION , 2002, The Journal of parasitology.

[24]  M. Yazdanbakhsh,et al.  Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood , 2001, The Lancet.

[25]  G. Punkosdy,et al.  Characterization of Antibody Responses to Wolbachia Surface Protein in Humans with Lymphatic Filariasis , 2003, Infection and Immunity.

[26]  A. Hoerauf,et al.  Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment , 2001, The Lancet.

[27]  M. Blaxter,et al.  Phylogeny of Wolbachia in filarial nematodes , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.